.webp/jcr:content.webp)
Diabetes
Get a global overview and learn all about the changing world of Diabetes.
Science in Diabetes
Get a 360º view and stay updated on Diabetes with content selected for you
Prevalence of Type 1 Diabetes and Daily Life Impact
Expert thoughts on the rising prevalence of Type 1 Diabetes and its implications for public health. Type 1 diabetes represents few diabetes cases globally, creating both physical and psychological challenges.
Navigation in Type 1 Diabetes
Type 1 Diabetes is a global health concern affecting millions worldwide. To address this issue effectively, it's crucial to assess our progress in diabetes research. Let's delve deeper into the autoimmune aspects and explore the underlying mechanisms of Type 1 Diabetes to enhance our understanding and improve management.
Stages of Type 1 Diabetes and DKA Impact
Type 1 diabetes progresses from presymptomatic autoimmunity to symptomatic hyperglycemia, ultimately requiring lifelong insulin therapy. DKA can cause severe metabolic imbalances requiring hospitalization, significantly disrupting daily life and posing serious health risks.
Recommendation for Screening
Screening for individuals with first-degree relatives with T1D, particularly those with high-risk and Regular monitoring of autoantibodies and glucose tolerance can facilitate earlier diagnosis and treatment initiation.
Early Detection and Intervention
Early identification of autoantibodies can help predict T1D development before symptoms appear.
Inspiration and innovation
Get inspired and stay at the forefront of innovation with the following resources
Advancing Therapy with iGlarLixi: Differentiation from other complex regimens
An educational video outlining key data from indirect comparisons of iGlarLixi versus IDegAsp.
Advancing Therapy with iGlarLixi: Differentiation from complex insulin regimens
An educational video outlining key data from indirect comparisons of iGlarLixi versus IDegAsp.
Treatment simplification of complex insulin regimens in T2D
An educational video to discuss the challenges associated with commonly-used insulin advancement options and the need for treatment simplification for many adults with T2D. The video reviews data supporting the use of BI + GLP-1 RA FRCs versus commonly-used insulin regimens in adults with T2D.
Insulin advancement in Type 2 diabetes: Unmet needs with commonly-used options
Educational video on "Insulin advancement in Type 2 diabetes: Unmet needs with commonly-used options" outlining key data from indirect comparisons of iGlarLixi versus IDegAsp.
Glargine 300 use in people with type 2 diabetes who fast during Ramadan
Watch Professor Mohamed Hassanein, consultant endocrinologist in Dubai Hospital, Dubai Health Authority and the chair of Diabetes and Ramadan International Alliance shedding the light on what are the unmet needs amongst Muslims with Type 2 diabetes when fast during Ramadan.
Events
Stay up to date and register for the latest events and view webinar recordings.
